nodes	percent_of_prediction	percent_of_DWPC	metapath
Granisetron—CYP1A1—Clobetasol propionate—psoriasis	0.171	0.23	CbGbCtD
Granisetron—CYP1A1—Methoxsalen—psoriasis	0.0897	0.121	CbGbCtD
Granisetron—CYP3A5—Beclomethasone—psoriasis	0.0776	0.105	CbGbCtD
Granisetron—CYP1A1—Cholecalciferol—psoriasis	0.0594	0.0802	CbGbCtD
Granisetron—CYP2D6—Hydroxyurea—psoriasis	0.0361	0.0487	CbGbCtD
Granisetron—CYP3A5—Mycophenolate mofetil—psoriasis	0.0309	0.0417	CbGbCtD
Granisetron—CYP3A4—Calcitriol—psoriasis	0.027	0.0364	CbGbCtD
Granisetron—CYP1A1—Dexamethasone—psoriasis	0.0257	0.0347	CbGbCtD
Granisetron—CYP3A5—Hydrocortisone—psoriasis	0.0248	0.0335	CbGbCtD
Granisetron—CYP3A5—Cyclosporine—psoriasis	0.0234	0.0316	CbGbCtD
Granisetron—CYP2D6—Cholecalciferol—psoriasis	0.0219	0.0295	CbGbCtD
Granisetron—CYP3A4—Methoxsalen—psoriasis	0.021	0.0283	CbGbCtD
Granisetron—CYP3A5—Dexamethasone—psoriasis	0.0154	0.0208	CbGbCtD
Granisetron—CYP2D6—Cyclosporine—psoriasis	0.0144	0.0194	CbGbCtD
Granisetron—CYP3A4—Cholecalciferol—psoriasis	0.0139	0.0188	CbGbCtD
Granisetron—CYP3A4—Mycophenolate mofetil—psoriasis	0.0121	0.0163	CbGbCtD
Granisetron—CYP3A4—Triamcinolone—psoriasis	0.0121	0.0163	CbGbCtD
Granisetron—CYP3A4—Betamethasone—psoriasis	0.0103	0.014	CbGbCtD
Granisetron—CYP3A4—Prednisolone—psoriasis	0.0102	0.0138	CbGbCtD
Granisetron—CYP3A4—Hydrocortisone—psoriasis	0.00967	0.0131	CbGbCtD
Granisetron—CYP3A4—Prednisone—psoriasis	0.00964	0.013	CbGbCtD
Granisetron—CYP2D6—Dexamethasone—psoriasis	0.00946	0.0128	CbGbCtD
Granisetron—CYP3A4—Cyclosporine—psoriasis	0.00913	0.0123	CbGbCtD
Granisetron—CYP3A4—Dexamethasone—psoriasis	0.00602	0.00812	CbGbCtD
Granisetron—CYP2D6—CYP2E1 reactions—CYP2S1—psoriasis	0.000212	0.0786	CbGpPWpGaD
Granisetron—CYP2D6—Miscellaneous substrates—CYP2S1—psoriasis	0.000197	0.0733	CbGpPWpGaD
Granisetron—CYP3A5—Xenobiotics—CYP2S1—psoriasis	0.000184	0.0685	CbGpPWpGaD
Granisetron—CYP1A1—Xenobiotics—CYP2S1—psoriasis	0.000174	0.0647	CbGpPWpGaD
Granisetron—CYP2D6—Xenobiotics—CYP2S1—psoriasis	0.000131	0.0487	CbGpPWpGaD
Granisetron—Feeling abnormal—Cyclosporine—psoriasis	0.000118	0.000461	CcSEcCtD
Granisetron—Shock—Triamcinolone—psoriasis	0.000118	0.000461	CcSEcCtD
Granisetron—Insomnia—Prednisolone—psoriasis	0.000118	0.000461	CcSEcCtD
Granisetron—Alopecia—Prednisone—psoriasis	0.000118	0.000461	CcSEcCtD
Granisetron—Hepatobiliary disease—Methotrexate—psoriasis	0.000118	0.000459	CcSEcCtD
Granisetron—Gastrointestinal pain—Cyclosporine—psoriasis	0.000118	0.000458	CcSEcCtD
Granisetron—Loss of consciousness—Dexamethasone—psoriasis	0.000118	0.000458	CcSEcCtD
Granisetron—Loss of consciousness—Betamethasone—psoriasis	0.000118	0.000458	CcSEcCtD
Granisetron—Dizziness—Mycophenolic acid—psoriasis	0.000117	0.000458	CcSEcCtD
Granisetron—Epistaxis—Methotrexate—psoriasis	0.000117	0.000458	CcSEcCtD
Granisetron—Paraesthesia—Prednisolone—psoriasis	0.000117	0.000458	CcSEcCtD
Granisetron—Tachycardia—Triamcinolone—psoriasis	0.000117	0.000457	CcSEcCtD
Granisetron—Malnutrition—Prednisone—psoriasis	0.000116	0.000454	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000116	0.000453	CcSEcCtD
Granisetron—Hyperhidrosis—Triamcinolone—psoriasis	0.000116	0.000453	CcSEcCtD
Granisetron—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000116	0.00045	CcSEcCtD
Granisetron—Insomnia—Hydrocortisone—psoriasis	0.000116	0.00045	CcSEcCtD
Granisetron—Hypertension—Betamethasone—psoriasis	0.000115	0.00045	CcSEcCtD
Granisetron—Hypertension—Dexamethasone—psoriasis	0.000115	0.00045	CcSEcCtD
Granisetron—Paraesthesia—Hydrocortisone—psoriasis	0.000115	0.000447	CcSEcCtD
Granisetron—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000115	0.000447	CcSEcCtD
Granisetron—Urticaria—Cyclosporine—psoriasis	0.000114	0.000445	CcSEcCtD
Granisetron—Body temperature increased—Cyclosporine—psoriasis	0.000114	0.000443	CcSEcCtD
Granisetron—Abdominal pain—Cyclosporine—psoriasis	0.000114	0.000443	CcSEcCtD
Granisetron—Anxiety—Dexamethasone—psoriasis	0.000113	0.000442	CcSEcCtD
Granisetron—Anxiety—Betamethasone—psoriasis	0.000113	0.000442	CcSEcCtD
Granisetron—Vomiting—Mycophenolic acid—psoriasis	0.000113	0.00044	CcSEcCtD
Granisetron—Discomfort—Dexamethasone—psoriasis	0.000112	0.000438	CcSEcCtD
Granisetron—Discomfort—Betamethasone—psoriasis	0.000112	0.000438	CcSEcCtD
Granisetron—Dyspepsia—Hydrocortisone—psoriasis	0.000112	0.000438	CcSEcCtD
Granisetron—Rash—Mycophenolic acid—psoriasis	0.000112	0.000436	CcSEcCtD
Granisetron—Dermatitis—Mycophenolic acid—psoriasis	0.000112	0.000436	CcSEcCtD
Granisetron—Pain—Prednisolone—psoriasis	0.000112	0.000436	CcSEcCtD
Granisetron—Urticaria—Mycophenolate mofetil—psoriasis	0.000111	0.000434	CcSEcCtD
Granisetron—Headache—Mycophenolic acid—psoriasis	0.000111	0.000434	CcSEcCtD
Granisetron—Decreased appetite—Hydrocortisone—psoriasis	0.000111	0.000433	CcSEcCtD
Granisetron—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000111	0.000432	CcSEcCtD
Granisetron—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000111	0.000432	CcSEcCtD
Granisetron—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.00011	0.00043	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.00011	0.000427	CcSEcCtD
Granisetron—Pain—Hydrocortisone—psoriasis	0.000109	0.000426	CcSEcCtD
Granisetron—Oedema—Betamethasone—psoriasis	0.000109	0.000425	CcSEcCtD
Granisetron—Oedema—Dexamethasone—psoriasis	0.000109	0.000425	CcSEcCtD
Granisetron—Anaphylactic shock—Dexamethasone—psoriasis	0.000109	0.000425	CcSEcCtD
Granisetron—Anaphylactic shock—Betamethasone—psoriasis	0.000109	0.000425	CcSEcCtD
Granisetron—Insomnia—Triamcinolone—psoriasis	0.000109	0.000424	CcSEcCtD
Granisetron—Infection—Dexamethasone—psoriasis	0.000108	0.000422	CcSEcCtD
Granisetron—Infection—Betamethasone—psoriasis	0.000108	0.000422	CcSEcCtD
Granisetron—Ill-defined disorder—Prednisone—psoriasis	0.000108	0.000421	CcSEcCtD
Granisetron—Paraesthesia—Triamcinolone—psoriasis	0.000108	0.000421	CcSEcCtD
Granisetron—Feeling abnormal—Prednisolone—psoriasis	0.000108	0.00042	CcSEcCtD
Granisetron—Visual impairment—Methotrexate—psoriasis	0.000108	0.00042	CcSEcCtD
Granisetron—Anaemia—Prednisone—psoriasis	0.000108	0.000419	CcSEcCtD
Granisetron—Shock—Dexamethasone—psoriasis	0.000107	0.000418	CcSEcCtD
Granisetron—Shock—Betamethasone—psoriasis	0.000107	0.000418	CcSEcCtD
Granisetron—Dyspnoea—Triamcinolone—psoriasis	0.000107	0.000418	CcSEcCtD
Granisetron—Nervous system disorder—Dexamethasone—psoriasis	0.000107	0.000417	CcSEcCtD
Granisetron—Nervous system disorder—Betamethasone—psoriasis	0.000107	0.000417	CcSEcCtD
Granisetron—Agitation—Prednisone—psoriasis	0.000107	0.000417	CcSEcCtD
Granisetron—Thrombocytopenia—Betamethasone—psoriasis	0.000107	0.000416	CcSEcCtD
Granisetron—Thrombocytopenia—Dexamethasone—psoriasis	0.000107	0.000416	CcSEcCtD
Granisetron—Tachycardia—Betamethasone—psoriasis	0.000107	0.000415	CcSEcCtD
Granisetron—Tachycardia—Dexamethasone—psoriasis	0.000107	0.000415	CcSEcCtD
Granisetron—Hypersensitivity—Cyclosporine—psoriasis	0.000106	0.000413	CcSEcCtD
Granisetron—Dyspepsia—Triamcinolone—psoriasis	0.000106	0.000412	CcSEcCtD
Granisetron—Nausea—Mycophenolic acid—psoriasis	0.000106	0.000411	CcSEcCtD
Granisetron—Hyperhidrosis—Dexamethasone—psoriasis	0.000106	0.000411	CcSEcCtD
Granisetron—Hyperhidrosis—Betamethasone—psoriasis	0.000106	0.000411	CcSEcCtD
Granisetron—Feeling abnormal—Hydrocortisone—psoriasis	0.000105	0.00041	CcSEcCtD
Granisetron—Malaise—Prednisone—psoriasis	0.000105	0.000409	CcSEcCtD
Granisetron—Vertigo—Prednisone—psoriasis	0.000105	0.000408	CcSEcCtD
Granisetron—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000104	0.000407	CcSEcCtD
Granisetron—Syncope—Prednisone—psoriasis	0.000104	0.000407	CcSEcCtD
Granisetron—Urticaria—Prednisolone—psoriasis	0.000104	0.000405	CcSEcCtD
Granisetron—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000103	0.000402	CcSEcCtD
Granisetron—Asthenia—Cyclosporine—psoriasis	0.000103	0.000402	CcSEcCtD
Granisetron—Pain—Triamcinolone—psoriasis	0.000103	0.000401	CcSEcCtD
Granisetron—Loss of consciousness—Prednisone—psoriasis	0.000102	0.000399	CcSEcCtD
Granisetron—Hypotension—Dexamethasone—psoriasis	0.000102	0.000397	CcSEcCtD
Granisetron—Hypotension—Betamethasone—psoriasis	0.000102	0.000397	CcSEcCtD
Granisetron—Pruritus—Cyclosporine—psoriasis	0.000102	0.000396	CcSEcCtD
Granisetron—Urticaria—Hydrocortisone—psoriasis	0.000101	0.000395	CcSEcCtD
Granisetron—Angiopathy—Methotrexate—psoriasis	0.000101	0.000395	CcSEcCtD
Granisetron—Body temperature increased—Hydrocortisone—psoriasis	0.000101	0.000393	CcSEcCtD
Granisetron—Abdominal pain—Hydrocortisone—psoriasis	0.000101	0.000393	CcSEcCtD
Granisetron—Asthenia—Mycophenolate mofetil—psoriasis	0.000101	0.000392	CcSEcCtD
Granisetron—Hypertension—Prednisone—psoriasis	0.000101	0.000392	CcSEcCtD
Granisetron—Chills—Methotrexate—psoriasis	0.0001	0.000391	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Betamethasone—psoriasis	9.94e-05	0.000387	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Dexamethasone—psoriasis	9.94e-05	0.000387	CcSEcCtD
Granisetron—Pruritus—Mycophenolate mofetil—psoriasis	9.92e-05	0.000386	CcSEcCtD
Granisetron—Arthralgia—Prednisone—psoriasis	9.92e-05	0.000386	CcSEcCtD
Granisetron—Feeling abnormal—Triamcinolone—psoriasis	9.91e-05	0.000386	CcSEcCtD
Granisetron—Anxiety—Prednisone—psoriasis	9.88e-05	0.000385	CcSEcCtD
Granisetron—Alopecia—Methotrexate—psoriasis	9.88e-05	0.000385	CcSEcCtD
Granisetron—Insomnia—Betamethasone—psoriasis	9.87e-05	0.000385	CcSEcCtD
Granisetron—Insomnia—Dexamethasone—psoriasis	9.87e-05	0.000385	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	9.85e-05	0.000384	CcSEcCtD
Granisetron—Diarrhoea—Cyclosporine—psoriasis	9.84e-05	0.000383	CcSEcCtD
Granisetron—Paraesthesia—Betamethasone—psoriasis	9.8e-05	0.000382	CcSEcCtD
Granisetron—Paraesthesia—Dexamethasone—psoriasis	9.8e-05	0.000382	CcSEcCtD
Granisetron—Discomfort—Prednisone—psoriasis	9.8e-05	0.000382	CcSEcCtD
Granisetron—Malnutrition—Methotrexate—psoriasis	9.73e-05	0.000379	CcSEcCtD
Granisetron—Hypersensitivity—Prednisolone—psoriasis	9.64e-05	0.000375	CcSEcCtD
Granisetron—Dyspepsia—Dexamethasone—psoriasis	9.61e-05	0.000374	CcSEcCtD
Granisetron—Dyspepsia—Betamethasone—psoriasis	9.61e-05	0.000374	CcSEcCtD
Granisetron—Diarrhoea—Mycophenolate mofetil—psoriasis	9.59e-05	0.000374	CcSEcCtD
Granisetron—Urticaria—Triamcinolone—psoriasis	9.56e-05	0.000372	CcSEcCtD
Granisetron—Dysgeusia—Methotrexate—psoriasis	9.53e-05	0.000371	CcSEcCtD
Granisetron—Body temperature increased—Triamcinolone—psoriasis	9.51e-05	0.00037	CcSEcCtD
Granisetron—Dizziness—Cyclosporine—psoriasis	9.51e-05	0.00037	CcSEcCtD
Granisetron—Oedema—Prednisone—psoriasis	9.51e-05	0.00037	CcSEcCtD
Granisetron—Anaphylactic shock—Prednisone—psoriasis	9.51e-05	0.00037	CcSEcCtD
Granisetron—Decreased appetite—Betamethasone—psoriasis	9.49e-05	0.00037	CcSEcCtD
Granisetron—Decreased appetite—Dexamethasone—psoriasis	9.49e-05	0.00037	CcSEcCtD
Granisetron—Infection—Prednisone—psoriasis	9.44e-05	0.000368	CcSEcCtD
Granisetron—Gastrointestinal disorder—Betamethasone—psoriasis	9.42e-05	0.000367	CcSEcCtD
Granisetron—Gastrointestinal disorder—Dexamethasone—psoriasis	9.42e-05	0.000367	CcSEcCtD
Granisetron—Hypersensitivity—Hydrocortisone—psoriasis	9.41e-05	0.000367	CcSEcCtD
Granisetron—Shock—Prednisone—psoriasis	9.35e-05	0.000364	CcSEcCtD
Granisetron—Pain—Betamethasone—psoriasis	9.33e-05	0.000364	CcSEcCtD
Granisetron—Pain—Dexamethasone—psoriasis	9.33e-05	0.000364	CcSEcCtD
Granisetron—Nervous system disorder—Prednisone—psoriasis	9.32e-05	0.000363	CcSEcCtD
Granisetron—Tachycardia—Prednisone—psoriasis	9.28e-05	0.000361	CcSEcCtD
Granisetron—Dizziness—Mycophenolate mofetil—psoriasis	9.27e-05	0.000361	CcSEcCtD
Granisetron—Skin disorder—Prednisone—psoriasis	9.23e-05	0.00036	CcSEcCtD
Granisetron—Hyperhidrosis—Prednisone—psoriasis	9.19e-05	0.000358	CcSEcCtD
Granisetron—Asthenia—Hydrocortisone—psoriasis	9.17e-05	0.000357	CcSEcCtD
Granisetron—Vomiting—Cyclosporine—psoriasis	9.14e-05	0.000356	CcSEcCtD
Granisetron—Rash—Cyclosporine—psoriasis	9.06e-05	0.000353	CcSEcCtD
Granisetron—Dermatitis—Cyclosporine—psoriasis	9.06e-05	0.000353	CcSEcCtD
Granisetron—Pruritus—Hydrocortisone—psoriasis	9.04e-05	0.000352	CcSEcCtD
Granisetron—Ill-defined disorder—Methotrexate—psoriasis	9.03e-05	0.000352	CcSEcCtD
Granisetron—Headache—Cyclosporine—psoriasis	9.01e-05	0.000351	CcSEcCtD
Granisetron—Anaemia—Methotrexate—psoriasis	9e-05	0.00035	CcSEcCtD
Granisetron—Feeling abnormal—Betamethasone—psoriasis	8.99e-05	0.00035	CcSEcCtD
Granisetron—Feeling abnormal—Dexamethasone—psoriasis	8.99e-05	0.00035	CcSEcCtD
Granisetron—Gastrointestinal pain—Betamethasone—psoriasis	8.93e-05	0.000348	CcSEcCtD
Granisetron—Gastrointestinal pain—Dexamethasone—psoriasis	8.93e-05	0.000348	CcSEcCtD
Granisetron—Vomiting—Mycophenolate mofetil—psoriasis	8.92e-05	0.000347	CcSEcCtD
Granisetron—Hypersensitivity—Triamcinolone—psoriasis	8.86e-05	0.000345	CcSEcCtD
Granisetron—Rash—Mycophenolate mofetil—psoriasis	8.84e-05	0.000344	CcSEcCtD
Granisetron—Dermatitis—Mycophenolate mofetil—psoriasis	8.83e-05	0.000344	CcSEcCtD
Granisetron—Headache—Mycophenolate mofetil—psoriasis	8.78e-05	0.000342	CcSEcCtD
Granisetron—Malaise—Methotrexate—psoriasis	8.78e-05	0.000342	CcSEcCtD
Granisetron—Vertigo—Methotrexate—psoriasis	8.74e-05	0.000341	CcSEcCtD
Granisetron—Diarrhoea—Hydrocortisone—psoriasis	8.74e-05	0.00034	CcSEcCtD
Granisetron—Leukopenia—Methotrexate—psoriasis	8.71e-05	0.000339	CcSEcCtD
Granisetron—Urticaria—Betamethasone—psoriasis	8.67e-05	0.000338	CcSEcCtD
Granisetron—Urticaria—Dexamethasone—psoriasis	8.67e-05	0.000338	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Prednisone—psoriasis	8.66e-05	0.000337	CcSEcCtD
Granisetron—Dizziness—Prednisolone—psoriasis	8.65e-05	0.000337	CcSEcCtD
Granisetron—Asthenia—Triamcinolone—psoriasis	8.63e-05	0.000336	CcSEcCtD
Granisetron—Abdominal pain—Dexamethasone—psoriasis	8.63e-05	0.000336	CcSEcCtD
Granisetron—Abdominal pain—Betamethasone—psoriasis	8.63e-05	0.000336	CcSEcCtD
Granisetron—Body temperature increased—Dexamethasone—psoriasis	8.63e-05	0.000336	CcSEcCtD
Granisetron—Body temperature increased—Betamethasone—psoriasis	8.63e-05	0.000336	CcSEcCtD
Granisetron—Insomnia—Prednisone—psoriasis	8.6e-05	0.000335	CcSEcCtD
Granisetron—CYP3A4—Xenobiotics—CYP2S1—psoriasis	8.57e-05	0.0319	CbGpPWpGaD
Granisetron—Nausea—Cyclosporine—psoriasis	8.54e-05	0.000333	CcSEcCtD
Granisetron—Paraesthesia—Prednisone—psoriasis	8.54e-05	0.000332	CcSEcCtD
Granisetron—Pruritus—Triamcinolone—psoriasis	8.51e-05	0.000332	CcSEcCtD
Granisetron—Cough—Methotrexate—psoriasis	8.49e-05	0.000331	CcSEcCtD
Granisetron—Dizziness—Hydrocortisone—psoriasis	8.45e-05	0.000329	CcSEcCtD
Granisetron—Dyspepsia—Prednisone—psoriasis	8.37e-05	0.000326	CcSEcCtD
Granisetron—Nausea—Mycophenolate mofetil—psoriasis	8.33e-05	0.000324	CcSEcCtD
Granisetron—Chest pain—Methotrexate—psoriasis	8.29e-05	0.000323	CcSEcCtD
Granisetron—Arthralgia—Methotrexate—psoriasis	8.29e-05	0.000323	CcSEcCtD
Granisetron—Decreased appetite—Prednisone—psoriasis	8.26e-05	0.000322	CcSEcCtD
Granisetron—Rash—Prednisolone—psoriasis	8.25e-05	0.000321	CcSEcCtD
Granisetron—Dermatitis—Prednisolone—psoriasis	8.24e-05	0.000321	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	8.23e-05	0.000321	CcSEcCtD
Granisetron—Headache—Prednisolone—psoriasis	8.19e-05	0.000319	CcSEcCtD
Granisetron—Discomfort—Methotrexate—psoriasis	8.19e-05	0.000319	CcSEcCtD
Granisetron—Constipation—Prednisone—psoriasis	8.13e-05	0.000317	CcSEcCtD
Granisetron—Vomiting—Hydrocortisone—psoriasis	8.12e-05	0.000316	CcSEcCtD
Granisetron—Rash—Hydrocortisone—psoriasis	8.05e-05	0.000314	CcSEcCtD
Granisetron—Dermatitis—Hydrocortisone—psoriasis	8.05e-05	0.000313	CcSEcCtD
Granisetron—Headache—Hydrocortisone—psoriasis	8e-05	0.000312	CcSEcCtD
Granisetron—Dizziness—Triamcinolone—psoriasis	7.95e-05	0.00031	CcSEcCtD
Granisetron—Anaphylactic shock—Methotrexate—psoriasis	7.94e-05	0.000309	CcSEcCtD
Granisetron—Infection—Methotrexate—psoriasis	7.89e-05	0.000307	CcSEcCtD
Granisetron—Feeling abnormal—Prednisone—psoriasis	7.83e-05	0.000305	CcSEcCtD
Granisetron—Asthenia—Dexamethasone—psoriasis	7.83e-05	0.000305	CcSEcCtD
Granisetron—Asthenia—Betamethasone—psoriasis	7.83e-05	0.000305	CcSEcCtD
Granisetron—Nervous system disorder—Methotrexate—psoriasis	7.79e-05	0.000303	CcSEcCtD
Granisetron—Thrombocytopenia—Methotrexate—psoriasis	7.78e-05	0.000303	CcSEcCtD
Granisetron—Gastrointestinal pain—Prednisone—psoriasis	7.77e-05	0.000303	CcSEcCtD
Granisetron—Nausea—Prednisolone—psoriasis	7.77e-05	0.000303	CcSEcCtD
Granisetron—Pruritus—Dexamethasone—psoriasis	7.72e-05	0.000301	CcSEcCtD
Granisetron—Pruritus—Betamethasone—psoriasis	7.72e-05	0.000301	CcSEcCtD
Granisetron—Skin disorder—Methotrexate—psoriasis	7.72e-05	0.000301	CcSEcCtD
Granisetron—Hyperhidrosis—Methotrexate—psoriasis	7.68e-05	0.000299	CcSEcCtD
Granisetron—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	7.66e-05	0.0284	CbGpPWpGaD
Granisetron—Vomiting—Triamcinolone—psoriasis	7.65e-05	0.000298	CcSEcCtD
Granisetron—Nausea—Hydrocortisone—psoriasis	7.59e-05	0.000296	CcSEcCtD
Granisetron—Rash—Triamcinolone—psoriasis	7.58e-05	0.000295	CcSEcCtD
Granisetron—Dermatitis—Triamcinolone—psoriasis	7.58e-05	0.000295	CcSEcCtD
Granisetron—CYP3A5—Oxidation by Cytochrome P450—CYP2S1—psoriasis	7.56e-05	0.0281	CbGpPWpGaD
Granisetron—Urticaria—Prednisone—psoriasis	7.55e-05	0.000294	CcSEcCtD
Granisetron—Headache—Triamcinolone—psoriasis	7.54e-05	0.000294	CcSEcCtD
Granisetron—Abdominal pain—Prednisone—psoriasis	7.51e-05	0.000293	CcSEcCtD
Granisetron—Body temperature increased—Prednisone—psoriasis	7.51e-05	0.000293	CcSEcCtD
Granisetron—Diarrhoea—Dexamethasone—psoriasis	7.47e-05	0.000291	CcSEcCtD
Granisetron—Diarrhoea—Betamethasone—psoriasis	7.47e-05	0.000291	CcSEcCtD
Granisetron—Hypotension—Methotrexate—psoriasis	7.42e-05	0.000289	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Methotrexate—psoriasis	7.24e-05	0.000282	CcSEcCtD
Granisetron—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	7.23e-05	0.0269	CbGpPWpGaD
Granisetron—Dizziness—Dexamethasone—psoriasis	7.22e-05	0.000281	CcSEcCtD
Granisetron—Dizziness—Betamethasone—psoriasis	7.22e-05	0.000281	CcSEcCtD
Granisetron—Insomnia—Methotrexate—psoriasis	7.18e-05	0.00028	CcSEcCtD
Granisetron—Nausea—Triamcinolone—psoriasis	7.15e-05	0.000278	CcSEcCtD
Granisetron—CYP1A1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	7.14e-05	0.0265	CbGpPWpGaD
Granisetron—Paraesthesia—Methotrexate—psoriasis	7.13e-05	0.000278	CcSEcCtD
Granisetron—Dyspnoea—Methotrexate—psoriasis	7.08e-05	0.000276	CcSEcCtD
Granisetron—Somnolence—Methotrexate—psoriasis	7.06e-05	0.000275	CcSEcCtD
Granisetron—Hypersensitivity—Prednisone—psoriasis	7e-05	0.000273	CcSEcCtD
Granisetron—Dyspepsia—Methotrexate—psoriasis	6.99e-05	0.000272	CcSEcCtD
Granisetron—Vomiting—Dexamethasone—psoriasis	6.94e-05	0.00027	CcSEcCtD
Granisetron—Vomiting—Betamethasone—psoriasis	6.94e-05	0.00027	CcSEcCtD
Granisetron—Decreased appetite—Methotrexate—psoriasis	6.91e-05	0.000269	CcSEcCtD
Granisetron—Rash—Dexamethasone—psoriasis	6.88e-05	0.000268	CcSEcCtD
Granisetron—Rash—Betamethasone—psoriasis	6.88e-05	0.000268	CcSEcCtD
Granisetron—Dermatitis—Betamethasone—psoriasis	6.88e-05	0.000268	CcSEcCtD
Granisetron—Dermatitis—Dexamethasone—psoriasis	6.88e-05	0.000268	CcSEcCtD
Granisetron—Gastrointestinal disorder—Methotrexate—psoriasis	6.86e-05	0.000267	CcSEcCtD
Granisetron—Headache—Dexamethasone—psoriasis	6.84e-05	0.000266	CcSEcCtD
Granisetron—Headache—Betamethasone—psoriasis	6.84e-05	0.000266	CcSEcCtD
Granisetron—Asthenia—Prednisone—psoriasis	6.82e-05	0.000266	CcSEcCtD
Granisetron—Pain—Methotrexate—psoriasis	6.79e-05	0.000265	CcSEcCtD
Granisetron—Pruritus—Prednisone—psoriasis	6.72e-05	0.000262	CcSEcCtD
Granisetron—Feeling abnormal—Methotrexate—psoriasis	6.55e-05	0.000255	CcSEcCtD
Granisetron—HTR3A—SIDS Susceptibility Pathways—RUNX3—psoriasis	6.54e-05	0.0243	CbGpPWpGaD
Granisetron—Diarrhoea—Prednisone—psoriasis	6.5e-05	0.000253	CcSEcCtD
Granisetron—Gastrointestinal pain—Methotrexate—psoriasis	6.5e-05	0.000253	CcSEcCtD
Granisetron—Nausea—Dexamethasone—psoriasis	6.48e-05	0.000253	CcSEcCtD
Granisetron—Nausea—Betamethasone—psoriasis	6.48e-05	0.000253	CcSEcCtD
Granisetron—Urticaria—Methotrexate—psoriasis	6.31e-05	0.000246	CcSEcCtD
Granisetron—Dizziness—Prednisone—psoriasis	6.29e-05	0.000245	CcSEcCtD
Granisetron—Abdominal pain—Methotrexate—psoriasis	6.28e-05	0.000245	CcSEcCtD
Granisetron—Body temperature increased—Methotrexate—psoriasis	6.28e-05	0.000245	CcSEcCtD
Granisetron—CYP3A5—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	6.21e-05	0.0231	CbGpPWpGaD
Granisetron—Vomiting—Prednisone—psoriasis	6.04e-05	0.000235	CcSEcCtD
Granisetron—Rash—Prednisone—psoriasis	5.99e-05	0.000233	CcSEcCtD
Granisetron—Dermatitis—Prednisone—psoriasis	5.99e-05	0.000233	CcSEcCtD
Granisetron—Headache—Prednisone—psoriasis	5.95e-05	0.000232	CcSEcCtD
Granisetron—CYP1A1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	5.86e-05	0.0218	CbGpPWpGaD
Granisetron—Hypersensitivity—Methotrexate—psoriasis	5.85e-05	0.000228	CcSEcCtD
Granisetron—Asthenia—Methotrexate—psoriasis	5.7e-05	0.000222	CcSEcCtD
Granisetron—Nausea—Prednisone—psoriasis	5.65e-05	0.00022	CcSEcCtD
Granisetron—Pruritus—Methotrexate—psoriasis	5.62e-05	0.000219	CcSEcCtD
Granisetron—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	5.44e-05	0.0202	CbGpPWpGaD
Granisetron—Diarrhoea—Methotrexate—psoriasis	5.44e-05	0.000212	CcSEcCtD
Granisetron—CYP2D6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	5.37e-05	0.02	CbGpPWpGaD
Granisetron—Dizziness—Methotrexate—psoriasis	5.25e-05	0.000205	CcSEcCtD
Granisetron—HTR3A—SIDS Susceptibility Pathways—IL13—psoriasis	5.16e-05	0.0192	CbGpPWpGaD
Granisetron—Vomiting—Methotrexate—psoriasis	5.05e-05	0.000197	CcSEcCtD
Granisetron—Rash—Methotrexate—psoriasis	5.01e-05	0.000195	CcSEcCtD
Granisetron—Dermatitis—Methotrexate—psoriasis	5e-05	0.000195	CcSEcCtD
Granisetron—Headache—Methotrexate—psoriasis	4.98e-05	0.000194	CcSEcCtD
Granisetron—Nausea—Methotrexate—psoriasis	4.72e-05	0.000184	CcSEcCtD
Granisetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	4.41e-05	0.0164	CbGpPWpGaD
Granisetron—CYP1A1—Oxidative Stress—CAT—psoriasis	3.78e-05	0.0141	CbGpPWpGaD
Granisetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	3.56e-05	0.0132	CbGpPWpGaD
Granisetron—CYP1A1—Estrogen Receptor Pathway—JUN—psoriasis	3.55e-05	0.0132	CbGpPWpGaD
Granisetron—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	3.51e-05	0.0131	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	3.47e-05	0.0129	CbGpPWpGaD
Granisetron—CYP3A5—Biological oxidations—CYP2S1—psoriasis	3.3e-05	0.0123	CbGpPWpGaD
Granisetron—CYP3A5—Metapathway biotransformation—CYP2S1—psoriasis	3.25e-05	0.0121	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—IL10—psoriasis	3.23e-05	0.012	CbGpPWpGaD
Granisetron—CYP1A1—Biological oxidations—CYP2S1—psoriasis	3.12e-05	0.0116	CbGpPWpGaD
Granisetron—CYP1A1—Metapathway biotransformation—CYP2S1—psoriasis	3.07e-05	0.0114	CbGpPWpGaD
Granisetron—CYP1A1—Estrogen Receptor Pathway—STAT3—psoriasis	3.07e-05	0.0114	CbGpPWpGaD
Granisetron—CYP1A1—Melatonin metabolism and effects—APOE—psoriasis	3.02e-05	0.0112	CbGpPWpGaD
Granisetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	2.89e-05	0.0107	CbGpPWpGaD
Granisetron—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	2.85e-05	0.0106	CbGpPWpGaD
Granisetron—CYP1A1—Tryptophan metabolism—CAT—psoriasis	2.69e-05	0.00999	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—CYP2S1—psoriasis	2.34e-05	0.00871	CbGpPWpGaD
Granisetron—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	2.31e-05	0.00859	CbGpPWpGaD
Granisetron—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	2.27e-05	0.00845	CbGpPWpGaD
Granisetron—CYP1A1—PPARA activates gene expression—CARM1—psoriasis	2.18e-05	0.00808	CbGpPWpGaD
Granisetron—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CARM1—psoriasis	2.13e-05	0.00791	CbGpPWpGaD
Granisetron—HTR3A—Transmembrane transport of small molecules—CP—psoriasis	1.97e-05	0.00731	CbGpPWpGaD
Granisetron—HTR3A—Transmembrane transport of small molecules—CARM1—psoriasis	1.88e-05	0.00698	CbGpPWpGaD
Granisetron—CYP1A1—Melatonin metabolism and effects—NFKB1—psoriasis	1.8e-05	0.00667	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—CXCL8—psoriasis	1.77e-05	0.00656	CbGpPWpGaD
Granisetron—CYP1A1—Oxidative Stress—NFKB1—psoriasis	1.75e-05	0.0065	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—JUN—psoriasis	1.64e-05	0.0061	CbGpPWpGaD
Granisetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	1.64e-05	0.00608	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—NFKB1—psoriasis	1.58e-05	0.00587	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—CYP2S1—psoriasis	1.53e-05	0.0057	CbGpPWpGaD
Granisetron—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	1.51e-05	0.00562	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	1.49e-05	0.00555	CbGpPWpGaD
Granisetron—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	1.47e-05	0.00545	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—VEGFA—psoriasis	1.43e-05	0.00533	CbGpPWpGaD
Granisetron—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	1.35e-05	0.00502	CbGpPWpGaD
Granisetron—CYP3A4—Tryptophan metabolism—CAT—psoriasis	1.32e-05	0.00491	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	1.29e-05	0.00479	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	1.24e-05	0.00461	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—TNF—psoriasis	1.23e-05	0.00457	CbGpPWpGaD
Granisetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	1.14e-05	0.00424	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	1.13e-05	0.00419	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—IL6—psoriasis	9.92e-06	0.00369	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	9.66e-06	0.00359	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—TNF—psoriasis	9.66e-06	0.00359	CbGpPWpGaD
Granisetron—CYP1A1—PPARA activates gene expression—PPARG—psoriasis	9.05e-06	0.00336	CbGpPWpGaD
Granisetron—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	8.86e-06	0.00329	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—NDUFA5—psoriasis	6.63e-06	0.00246	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—NDUFA5—psoriasis	6.27e-06	0.00233	CbGpPWpGaD
Granisetron—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	6.11e-06	0.00227	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	5.84e-06	0.00217	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CYP2S1—psoriasis	5.64e-06	0.0021	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CYP2S1—psoriasis	5.33e-06	0.00198	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—NDUFA5—psoriasis	4.72e-06	0.00175	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CYP2S1—psoriasis	4.01e-06	0.00149	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—NDUFA5—psoriasis	3.08e-06	0.00115	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.79e-06	0.00104	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CARM1—psoriasis	2.75e-06	0.00102	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CYP2S1—psoriasis	2.62e-06	0.000974	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CARM1—psoriasis	2.6e-06	0.000967	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.43e-06	0.000904	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CARM1—psoriasis	1.96e-06	0.000728	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CAT—psoriasis	1.69e-06	0.000629	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CAT—psoriasis	1.6e-06	0.000595	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—APOE—psoriasis	1.32e-06	0.000489	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CARM1—psoriasis	1.28e-06	0.000476	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—APOE—psoriasis	1.24e-06	0.000462	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CAT—psoriasis	1.2e-06	0.000448	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PPARG—psoriasis	1.15e-06	0.000426	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PPARG—psoriasis	1.08e-06	0.000402	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—APOE—psoriasis	9.36e-07	0.000348	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PPARG—psoriasis	8.15e-07	0.000303	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CAT—psoriasis	7.87e-07	0.000293	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—APOE—psoriasis	6.12e-07	0.000227	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PPARG—psoriasis	5.33e-07	0.000198	CbGpPWpGaD
